Targeting tetraspanins in cancer. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Expert Opinion on Therapeutic Targets Année : 2012

Targeting tetraspanins in cancer.

Résumé

Introduction: Tetraspanins are a family of small proteins that cross the membrane four times and form complexes by interacting between themselves and with a variety of transmembrane and cytosolic proteins, building a network of interactions referred to as tetraspanin web or tetraspanin enriched microdomains (TEMs). These domains provide a signaling platform involved in many important cellular functions and malignant processes. Areas covered: The authors describe the methods and the rationale for targeting tetraspanins in the therapy of cancer in this review. Expert opinion: Targeting tetraspanins in cancer may be a promising therapy due to the importance of tetraspanins in several steps of tumor formation, communication with the environment, dissemination, and metastasis.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-00724944 , version 1 (23-08-2012)

Identifiants

Citer

Monica Sala-Valdes, Naouel Ailane, Céline Greco, Eric Rubinstein, Claude Boucheix. Targeting tetraspanins in cancer.. Expert Opinion on Therapeutic Targets, 2012, 32 (1), epub ahead of print. ⟨10.1517/14728222.2012.712688⟩. ⟨inserm-00724944⟩

Collections

INSERM
154 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More